Evidence map›Paper›PMID 40417401›Full record

ArticleFrontiers in molecular neuroscience2025

Changes in glycinergic neurotransmission alter mammalian retinal information processing.

Anneka Joachimsthaler, Katharina Hauf, Anja Armbruster, Shiri Zayit-Soudry, Efrat Naaman, Ido Perlman, Rina Leibu, Alina Kurolap, Hagit Baris Feldman, Jan Kremers and 1 more

Abstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The interaction between the ERG responses to sinusoidal modulation and flashes in mice.Documenta ophthalmologica. Advances in ophthalmology · 2026
    Article
  3. The area under the waveform as an alternative measure of the photopic negative response.Documenta ophthalmologica. Advances in ophthalmology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anneka Joachimsthaler *Department of Ophthalmology, University Hospital Erlangen, Erlangen, Germany.
Katharina Hauf *Department of Biochemistry and Molecular Medicine, Institute of Biochemistry, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Anja ArmbrusterDepartment of Biochemistry and Molecular Medicine, Institute of Biochemistry, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Shiri Zayit-SoudryDepartment of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Efrat NaamanDepartment of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Ido PerlmanThe Ruth & Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Rina LeibuDepartment of Ophthalmology, Rambam Human Health Care Campus, Haifa, Israel.
Alina KurolapThe Genetics Institute and Genomic Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Hagit Baris FeldmanThe Genetics Institute and Genomic Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Jan KremersDepartment of Ophthalmology, University Hospital Erlangen, Erlangen, Germany.
Volker EulenburgDepartment of Biochemistry and Molecular Medicine, Institute of Biochemistry, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycine, along with GABA, constitutes the major inhibitory neurotransmitter in the central nervous system. In the retina, glycinergic neurotransmission is primarily used by amacrine cells that are involved in the lateral processing of visual stimuli in the inner retina. We have previously shown that the high-affinity glycine transporter 1 (GlyT1), that is commonly used as a reliable marker for glycinergic amacrine cells in the retina, is essential for glycinergic neurotransmission by these cells. Abolishment of retinal GlyT1 expression results in a breakdown of glycinergic neurotransmission by AII amacrine cells, but most likely also by other glycinergic amacrine cell populations. However, the impact of loss of glycinergic neurotransmission on retinal signal processing and visually guided behavior, has not yet been elucidated. In this study, the effects of loss of retinal GlyT1 expression in glycinergic amacrine cells on the optomotor reflex and on the photopic and scotopic electroretinogram (ERG) responses were analyzed. We show that retinal GlyT1-deficient mice have normal optomotor responses to rotating black and white stripes. When stimuli with sawtooth luminance profiles were used, thereby differentially activating ON and OFF pathways, the GlyT1 deficient mice showed facilitated responses to ON preferring stimuli, whereas responses to OFF preferring stimuli were unchanged. These findings were corroborated by ERG recordings that showed undistinguishable responses after flash stimulation but revealed differences in the differential processing of ON and OFF preferring stimuli. To determine if the function of retinal GlyT1 is conserved in humans, we analyzed ERG recordings from a patient diagnosed with GlyT1 encephalopathy. We show that GlyT1 deficiency results in marked ERG changes, characterized by an almost complete loss of the "photopic hill" phenomenon, a hill-like appearance of the relationship between the b-wave amplitude and log light stimulus strength under background illumination conditions, and reductions in the ERG oscillatory potentials in the dark- and light-adapted states. Both findings are consistent with an altered interaction between ON- and OFF pathways in the retina. Taken together our data show that glycinergic neurotransmission in the retina has important functions in retinal ON and OFF processing both in mice and humans.

Indexed as

amacrine cellsERGglycinehumanmouseON-OFF signallingretinasynaptic inhibition

Identifiers

PMID40417401
PMCPMC12098532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.